Wan Peixing, Yan Jiong, Liu Zhenggang
Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA.
J Natl Cancer Cent. 2022 Dec;2(4):291-297. doi: 10.1016/j.jncc.2022.08.007. Epub 2022 Aug 28.
Necroptosis is currently attracting the attention of the scientific community for its broad implications in inflammatory diseases and cancer. However, detecting ongoing necroptosis under both experimental and clinical disease conditions remains challenging. The technical barrier lies in four aspects, namely tissue sampling, real-time monitoring, specific markers, and distinction between different types of cell death. In this review, we presented the latest methodological advances for necroptosis identification. The advances highlighted the multi-parameter flow cytometry, sA5-YFP tool, radiolabeled Annexin V/Duramycin, Gallium-68-labeled IRDye800CW contrast agent, and SMART platform . We also discussed the up-to-date research models in studying necroptosis, particularly the mice models for manipulating and monitoring necroptosis. Based on these recent advances, this review aims to provide some advice on current necroptosis techniques and approaches.
坏死性凋亡因其在炎症性疾病和癌症中的广泛影响,目前正吸引着科学界的关注。然而,在实验和临床疾病条件下检测正在进行的坏死性凋亡仍然具有挑战性。技术障碍存在于四个方面,即组织采样、实时监测、特异性标志物以及区分不同类型的细胞死亡。在这篇综述中,我们介绍了坏死性凋亡鉴定的最新方法进展。这些进展突出了多参数流式细胞术、sA5-YFP工具、放射性标记的膜联蛋白V/短杆菌肽、镓-68标记的IRDye800CW造影剂和SMART平台。我们还讨论了研究坏死性凋亡的最新研究模型,特别是用于操纵和监测坏死性凋亡的小鼠模型。基于这些最新进展,本综述旨在为当前坏死性凋亡技术和方法提供一些建议。